We showed that no matter the phenotype, the number of CD3+, FoxP3+ or CD45RO+ cells was highly variable from one tumor to the other and these cells were on average more frequent at the tumor margin, although the difference was not statistically significant (Figure 2). This evidence concerns the gene FOXP3 and neoplasm.